Although abnormal p53 has been consistently associated with a poor prognosis in patients with endometrial cancer [17,18,19,20,21,22,23,24], there are limited data and small series specifically addressing the association between p53 status and outcomes in G3 endometrioid endometrial carcinomas. This evidence concerns the gene TP53 and endometrial endometrioid carcinoma.